GRWP
ACTU

Green Ridge Wealth Planning’s Actuate Therapeutics ACTU Stock Holding History

Green Ridge Wealth Planning’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3K Buy
+10,000
New +$23.2K 0.01% 94

Other funds holding ACTU

GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Green Ridge Wealth Planning's ACTU Position: Q2 2026 in Review

Green Ridge Wealth Planning opened a new position in Actuate Therapeutics (ACTU) in Q2 2026: 10,000 shares worth $15.3K. The stake represents 0.01% of the portfolio and ranks #94 among its holdings.

5 funds tracked by Wall St. Rank hold ACTU as of Q2 2026.

  • Green Ridge Wealth Planning held 10,000 shares of Actuate Therapeutics worth $15.3K as of Q2 2026.
  • Actuate Therapeutics was a new Green Ridge Wealth Planning position in Q2 2026.
  • Actuate Therapeutics made up 0.01% of Green Ridge Wealth Planning's portfolio in Q2 2026, its #94 holding.
  • 5 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q2 2026.

Based on Green Ridge Wealth Planning's 13F filing for Q2 2026, filed 8 Jul 2026.